Haku
Viitteet 1-10 / 311
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
(2023-04)
- article
Background: Despite a clear link between aging and cancer, there has been inconclusive evidence on how biological age (BA) may be associated with cancer incidence. Methods: We studied 308,156 UK Biobank participants with ...
Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
(2023-04)
- article
Serum carcinoembryonic antigen (CEA) is frequently monitored to detect colorectal cancer (CRC) recurrence after surgery. The clinical significance of transiently increased CEA during adjuvant chemotherapy is poorly understood. ...
Geenit ja proteiinit kertovat lasten leukemian ennusteesta
(2022)
- article
Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment
(2021)
- article
In the era of personalized medicine, systemic treatment with chemotherapy in combination with targeted drugs, tailored according to RAS and BRAF status, has improved the survival of patients with metastatic colorectal ...
The pediatric precision oncology inform registry : Clinical outcome and benefit for patients with very high-evidence targets
(2021)
- article
INFORM is a prospective, multinational registry gathering clinical and molecular data of relapsed, progressive, or high-risk pediatric patients with cancer. This report describes long-term follow-up of 519 patients in whom ...
Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy : a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)
(2021)
- article
BACKGROUND: Colorectal cancer liver metastases respond to chemotherapy and targeted agents not only by shrinking, but also by morphologic and metabolic changes. The aim of this study was to evaluate the value of advanced ...
Subclone eradication analysis identifies targets for enhanced cancer therapy and reveals L1 retrotransposition as a dynamic source of cancer heterogeneity
(2021)
- article
Treatment-eradicated cancer subclones have been reported in leukemia and have recently been detected in solid tumors. Here we introduce Differential Subclone Eradication and Resistance (DSER) analysis, a method developed ...
Online follow-up with a mobile device improves incurable cancer patients’ coping : A qualitative study
(2021)
- article
Purpose To examine patients’ experiences regarding the impact of support given by a mobile application on their ability to cope with incurable cancer. Method The qualitative research data of semi-structured, face-to-face ...